Pharmaceutical manufacturing

FILE - In this July 10, 2018 file photo, bottles of prescription medicines ride on a conveyor belt at a pharmacy warehouse in Florence, N.J. According to a report released on Tuesday, Jan. 8, 2018, annual spending by the U.S. health industry on ads and promotions has reached $30 billion. That includes advertisements for prescription drugs that were shown 5 million times on TV and elsewhere in 2016. That’s a huge increase in 20 years and just part of broad health industry efforts to promote drugs, devices, lab tests and even new hospitals. (AP Photo/Julio Cortez, File)
January 08, 2019 - 2:29 pm
Ads for prescription drugs appeared 5 million times in just one year, capping a recent surge in U.S. medical marketing, a new analysis found. The advertisements for various medicines showed up on TV, newspapers, online sites and elsewhere in 2016. Their numbers soared over 20 years as part of broad...
Read More
January 07, 2019 - 3:11 pm
WASHINGTON (AP) — The Supreme Court seemed inclined Monday to side with drugmaker Merck & Co. in a dispute over the warning label on its bone-strengthening drug Fosamax. The justices heard arguments in a case involving hundreds of people who sued the Kenilworth, New Jersey-based drug company,...
Read More
FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 7:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
FILE - In this June 15, 2005, file photo, a sign stands in front of a Bristol-Myers Squibb building in a Lawrence Township, N.J. Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about $74 billion. (AP Photo/Mel Evans, File)
January 03, 2019 - 5:24 pm
SUMMIT, N.J. (AP) — Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal...
Read More
Stock trader Michael Milano works at the New York Stock Exchange, Wednesday, Dec. 19, 2018. (AP Photo/Mark Lennihan)
December 19, 2018 - 3:42 pm
NEW YORK (AP) — Stocks gave up an early rally and took a dive in afternoon trading after the Federal Reserve's raised interest rates again and said it plans to keep raising them next year. The U.S. central bank also said it wouldn't make any changes in allowing its large bond portfolio to shrink...
Read More
FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)
December 19, 2018 - 1:18 pm
Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies. The new joint venture would have with combined annual sales of $12.7 billion (9.8 billion...
Read More
FILE- In this Nov. 20, 2018, file photo pedestrians walk past the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Nov. 30 (AP Photo/Mary Altaffer, File)
November 30, 2018 - 1:51 pm
NEW YORK (AP) — Stocks are wavering Friday ahead of the highly anticipated trade meeting between President Donald Trump and President Xi Jinping of China. Investors have long hoped the two will use their meeting at the Group of 20 summit to start resolving the trade dispute between the two...
Read More
November 23, 2018 - 9:01 am
LONDON (AP) — A British corporate investigator has complained to U.K. regulators about Chinese state TV, saying its British license should be revoked because it broadcast his forced confession when he was imprisoned in China. Peter Humphrey filed a complaint Friday against China Central Television...
Read More
FILE - In this Dec. 14, 2017 file photo, an Israeli flag flies outside a Teva Pharmaceutical Industries building, in Neot Hovav, Israel. On Thursday, Nov. 1, 2018, Israeli drug maker Teva reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics business, the launch of new products and progress with its restructuring program. Its stock price surged on the news. (AP Photo/Tsafrir Abayov, File)
November 01, 2018 - 1:12 pm
JERUSALEM (AP) — Israeli drug maker Teva Pharmaceutical Industries on Thursday reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics...
Read More
FILE- This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Oct. 30, 2018. (AP Photo/Richard Drew, File)
October 30, 2018 - 1:13 pm
Pfizer posted a 45 percent jump in third-quarter profit, as the biggest U.S.-based drugmaker benefited from sharply lower taxes due to this year's federal tax cut. The maker of Viagra and nerve pain treatment Lyrica on Tuesday reported net income of $4.11 billion, or 69 cents per share. Adjusted...
Read More

Pages